You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xanthomatosis

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CDCA in CTX Chenodeoxycholic Acid in Patients Affected by

Completed
  • Cerebrotendinous Xanthomatoses
  • Chenodeoxycholic Acid
  • (no location specified)
Aug 10, 2022

Mutation of Cerebrotendinous Xanthomatosis (CTX)

Enrolling by invitation
  • Xanthomatosis, Cerebrotendinous
  • Mutation Analysis
  • Osmaniye, Turkey
    Osmaniye / Index Case 1 Family Village
Mar 30, 2021

Alagille Syndrome, Atorvastatin, Xanthoma Trial in Shanghai (atorvastatin)

Recruiting
  • Alagille Syndrome
  • +2 more
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Aug 3, 2022

ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn

Enrolling by invitation
  • Acid Sphingomyelinase Deficiency
  • +13 more
  • Confirmatory Testing
  • Bronx, New York
  • +9 more
May 9, 2022

Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in

Active, not recruiting
  • Rare Histiocytic Disorders (RHDs)
  • +7 more
  • Registry study
  • Los Angeles, California
  • +13 more
Dec 13, 2022

CTX Disorder in Juvenile Cataract Cases in Turkey

Recruiting
  • Cerebrotendinous Xanthomatosis
  • Blood sampling for Cholestanol Analysis
  • Adana, Turkey
  • +35 more
Mar 25, 2021

Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

Unknown status
  • Cerebrotendinous Xanthomatosis (CTX)
    • Birmingham, Alabama
    • +44 more
    Nov 7, 2018

    Ultra-rare Inherited Metabolic and Degenerative Neurological

    Recruiting
    • Inherited Disease
    • +5 more
    • collection of data
    • Milano, Italy
      Fondazione IRCCS Istituto Neurologico Carlo Besta
    May 6, 2021

    Alagille Syndrome Trial in Canada, United States (LUM001 (Maralixibat))

    Completed
    Has Results
    • Alagille Syndrome
    • LUM001 (Maralixibat)
    • Los Angeles, California
    • +10 more
    Jun 29, 2021

    Alagille Syndrome Trial in Birmingham, Leeds, London (LUM001 (Maralixibat))

    Completed
    Has Results
    • Alagille Syndrome
    • LUM001 (Maralixibat)
    • Birmingham, West Midlands, United Kingdom
    • +2 more
    Nov 17, 2021

    Lp(a) and Aortic Valve Calcification

    Completed
    • Heterozygous Familial Hypercholesterolemia
      • Quebec, Canada
        Institute of Nutrition and Functional Foods (INAF)
      Feb 20, 2020

      Half-life of Plasma Phytosterols in Very Low Birth Weight

      Completed
      • Liver Disease
        • (no location specified)
        Jan 22, 2018

        Half-life of Plasma Phytosterols in Preterm Infants on

        Completed
        • Liver Diseases
          • (no location specified)
          Apr 28, 2016

          Familial Hypercholesterolemia Trial in Quebec (Pre-lipid apheresis, Post-lipid apheresis)

          Completed
          • Familial Hypercholesterolemia
          • Pre-lipid apheresis
          • Post-lipid apheresis
          • Quebec, Canada
            Institute of Nutrition and Functional Foods (INAF)
          Mar 7, 2016

          Cerebrotendinous Xanthomatosis Trial in East Orange (Chenodeoxycholic Acid)

          Withdrawn
          • Cerebrotendinous Xanthomatosis
          • Chenodeoxycholic Acid
          • East Orange, New Jersey
            VA New Jersey Health Care System, East Orange
          Oct 11, 2013

          Carotid IMT and Atherogenic Risk Factors in Cerebrotendinous

          Unknown status
          • Cerebrotendinous Xanthomatosis (CTX)
          • Blood tests
          • Tel Hashomer, Israel
            The Bert W. Strassburger Lipid Center
          Jun 6, 2012

          Heart Diseases, Metabolism, Inborn Errors Trial run by the NHLBI (SCH-58235, Ezetimibe)

          Completed
          • Heart Diseases
          • Metabolism, Inborn Errors
          • Bethesda, Maryland
            National Heart, Lung and Blood Institute (NHLBI)
          Mar 3, 2008

          Lipoidosis Trial run by the NHLBI (SCH-58235)

          Completed
          • Lipoidosis
          • Bethesda, Maryland
            National Heart, Lung and Blood Institute (NHLBI)
          Mar 3, 2008

          Cerebrotendinous Xanthomatosis Trial in Portland (chenodeoxycholic acid, lovastatin)

          Unknown status
          • Cerebrotendinous Xanthomatosis
          • Portland, Oregon
            Oregon Health and Science University
          Jun 23, 2005